课题基金 / 基金详情

Analysis of cellular function of DYRK family protein kinases

Analysis of cellular function of DYRK family protein kinases
DYRK家族蛋白激酶的细胞功能分析
批准号:
17570110
负责人:
MIYATA Yoshihiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MIYATA Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The DYRK (Dual-specificity tYrosine-phosphorylation Regulated protein Kinase) family consists of several related protein kinases, DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4. DYRKs show significant homology to Drosophila Minibrain, and DYRK1A in human chromosome 21 has been shown to be responsible for the human Down's syndrome. Here we report identification of cellular proteins that associate with specific members of DYRKs. Cellular proteins with molecular masses of 90, 70, and 50-kDa associated specifically with DYRK1B and DYRK4, but not with other DYRKs. These proteins were identified as molecular chaperones Hsp90, Hsp70, and Cdc37, respectively. Microscopic analysis of GFP-DYRKs showed that DYRK1A and DYRK1B were nuclear, while DYRK2, DYRK3, and DYRK4 were mostly cytoplasmic. Treatment of cells with the specific Hsp90 inhibitor, geldanamycin, abolished the association of Hsp90 and Cdc37 with DYRK1B and DYRK4, but not of Hsp70. Inhibition of Hsp90 molecular chaperone activity affected the intracellular dynamics of DYRK1B and DYRK4, but not other DYRKs. DYRK1B and DYRK4 underwent rapid formation of cytoplasmic punctate dots after treatment of cells with geldanamycin, suggesting that the chaperone function of Hsp90 is required for the prevention of protein aggregation of target kinases. Prolonged inhibition of Hsp90 decreased the cellular levels of DYRK1B and DYRK4, but not other DYRKs. Finally, DYRK1B and DYRK4 were specifically ubiquitinated in cells, and the ubiquitinated DYRK1B and DYRK4 further increased by proteasome inhibition. Take together, these results indicate that Hsp90 and Cdc37 discriminate specific members of the DYRK kinase family and are required for the solubility and stability of these client kinases in cells.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
分子シャペロンHsp90阻害薬(ゲルダナマイシン)
分子伴侣 Hsp90 抑制剂(格尔德霉素)
DOI: --
发表时间: 2005
期刊: 癌治療と宿主 17
影响因子: --
作者: [Miyata, Y., Nishida, E., 宮田 愛彦]
通讯作者: 宮田 愛彦
An inhibitor of the molecular chaperone Hsp90 (geldanamycin) (in Japanese)
分子伴侣 Hsp90(格尔德霉素)的抑制剂(日语)
DOI: --
发表时间: 2005
期刊: Frontiers in Cancer Treatment 17
影响因子: --
作者: [Miyata, Y.]
通讯作者: Y.
DOI: 10.1007/s11010-005-2949-8
发表时间: 2005-06-01
期刊: MOLECULAR AND CELLULAR BIOCHEMISTRY
影响因子: 4.3
作者: [Miyata, Y, Nishida, E]
通讯作者: Nishida, E
Identification and functional analyses of cellular proteins that specifically interact with DYRK family protein kinases
  • 批准号:
    20570129
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2008
  • 负责人:
    MIYATA Yoshihiko
  • 依托单位:
Analysis of physiological role of protein kinase MOK, a novel member of MAP kinase superfamily
  • 批准号:
    13680781
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.3万
  • 财政年份:
    2001
  • 负责人:
    MIYATA Yoshihiko
  • 依托单位:
Identification and functional analysis of a novel type of MAP kinase superfamily.
  • 批准号:
    11680696
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    1999
  • 负责人:
    MIYATA Yoshihiko
  • 依托单位:
国内基金
海外基金
EB病毒类朊蛋白EBNA1通过分子伴侣HSP90调控相分离促进鼻咽癌恶性进展的机制研究
  • 批准号:
    2026JJ60271
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张宵月
  • 依托单位:
富血小板血浆外泌体通过靶向雪旺细胞sFRP1-巨噬细胞HSP90轴减轻神经病理性疼痛的机制研究
  • 批准号:
    2026JJ81668
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    左玲玲
  • 依托单位:
分子伴侣Hsp90/FKBP51复合物通过稳定PPARγ减轻糖尿病心缺血再灌注损伤的机制研究
  • 批准号:
    JCZRYB202500986
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
西花蓟马热休克蛋白Hsp90与番茄斑萎病毒NSs蛋白互作调控介体传毒机制研究
  • 批准号:
    2025JJ60138
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    陈建斌
  • 依托单位: